Abstract
Abstract Background Elexacaftor–tezacaftor–ivacaftor is a small-molecule cystic fibrosis transmembrane conductance regulator (CFTR) modulator regimen shown to be efficacious in patients with at lea...
Cite
CITATION STYLE
APA
Barry, P. J., Mall, M. A., Álvarez, A., Colombo, C., de Winter-de Groot, K. M., Fajac, I., … Polineni, D. (2021). Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes. New England Journal of Medicine, 385(9), 815–825. https://doi.org/10.1056/nejmoa2100665
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free